Aducanumab produced a clinically meaningful benefit in association with amyloid lowering

Authors

Jeffrey Cummings, University of Nevada, Las Vegas
Paul Aisen, University of Southern California
Cynthia Lemere, Harvard Medical School
Alireza Atri, Banner Sun Health Research Institute
Marwan Sabbagh, Cleveland Clinic Lou Ruvo Center for Brain HealthFollow
Stephen Salloway, Butler Hospital

Document Type

Article

Publication Date

12-1-2021

Publication Title

Alzheimer's Research and Therapy

E-ISSN

17589193

Volume

13

Issue

1

PubMed ID

33971962

Digital Object Identifier (DOI)

10.1186/s13195-021-00838-z

Recommended Citation

Cummings, Jeffrey; Aisen, Paul; Lemere, Cynthia; Atri, Alireza; Sabbagh, Marwan; and Salloway, Stephen, "Aducanumab produced a clinically meaningful benefit in association with amyloid lowering" (2021). Neurology. 738.
https://scholar.barrowneuro.org/neurology/738